Literature DB >> 27992694

A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Nayef M Kazzaz1, Allecia M Wilson1, Ruba Kado1, Geoffrey D Barnes1, Jason S Knight1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27992694      PMCID： PMC5476509          DOI： 10.1002/acr.23168

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  39 in total

Review 1.  Coronary artery pathology.

Authors:  Allard C van der Wal
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

Review 2.  The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.

Authors:  Mirhelen M Abreu; Adriana Danowski; Denis G Wahl; Mary-Carmen Amigo; Maria Tektonidou; Marcelo S Pacheco; Norma Fleming; Vinicius Domingues; Savino Sciascia; Julia O Lyra; Michelle Petri; Munther Khamashta; Roger A Levy
Journal:  Autoimmun Rev       Date:  2015-01-29       Impact factor: 9.754

3.  Angiographic features associated with antiphospholipid syndrome.

Authors:  N A Dongola; K D Foord
Journal:  Br J Radiol       Date:  2000-11       Impact factor: 3.039

Review 4.  Coronary and valvular syndromes and antiphospholipid antibodies.

Authors:  Ricard Cervera
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

5.  Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.

Authors:  Srilakshmi Yalavarthi; Travis J Gould; Ashish N Rao; Levi F Mazza; Alexandra E Morris; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Paula L Bockenstedt; Patricia C Liaw; Antonio R Cabral; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

Review 6.  Catastrophic APS in the context of other thrombotic microangiopathies.

Authors:  Ignasi Rodríguez-Pintó; Gerard Espinosa; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

7.  Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings.

Authors:  R García-Torres; M C Amigo; A de la Rosa; A Morón; P A Reyes
Journal:  Lupus       Date:  1996-02       Impact factor: 2.911

8.  Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura.

Authors:  C Montecucco; M Di Lauro; E Bobbio-Pallavicini; M Longhi; R Caporali; F De Gennaro; E Ascari
Journal:  Clin Exp Rheumatol       Date:  1987 Oct-Dec       Impact factor: 4.473

9.  Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases.

Authors:  K Yokoi; E Hosoi; M Akaike; T Shigekiyo; S Saito
Journal:  Angiology       Date:  1996-03       Impact factor: 3.619

Review 10.  Vasculitis associated with antiphospholipid syndrome.

Authors:  D K Norden; B E Ostrov; A B Shafritz; J M Von Feldt
Journal:  Semin Arthritis Rheum       Date:  1995-02       Impact factor: 5.532
View more
  3 in total

Review 1.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

2.  Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state.

Authors:  Elise Danielle McVeigh; Amna Batool; Arnold Stromberg; Ahmed Abdel-Latif; Nayef Mohammed Kazzaz
Journal:  Lupus Sci Med       Date:  2021-05

Review 3.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.